British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent rights in ...

Exclusive: U.S. prosecutors probe a politically explosive tip that Pfizer in 2020 delayed announcing a successful Covid-19 vaccine until after the election that Trump lost to Biden.

Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 shot. Novavax was expecting to hear back from the FDA about a full ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...

According to Pfizer and BioNTech, this is the first time that an mRNA-based flu vaccine has started a phase 3 efficacy trial.

The NHS spring booster campaign is offering Covid jab to groups of vulnerable patients across the UK. Around 7.5 million people in England are eligible for a top-up vaccination. Many pharmacies ...